Volume 99, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In many parts of the world, the case-fatality rate of infection approaches 60%. To evaluate the spectrum of disease associated with in Far North Queensland (FNQ), Australia, we reviewed all culture-confirmed isolates from 1997 to 2017. There were 28 isolates, 15 represented infection, 11 were contaminants, and two charts were destroyed preventing detailed evaluation of these cases. The most common sites of infection were the skin and soft tissue and the urinary tract; there were two cases of bacteremia without focus. There were no deaths attributable to during the study period and only two cases required intensive care unit support, although in both patients this was not for the infection, but for the management of other health issues. Globally, has a reputation as a deadly pathogen, but in FNQ, Australia, infections usually follow a relatively benign course.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Blereau RP, , 1980. Septicemia and death caused by Chromobacterium violaceum. South Med J 73: 10931094. [Google Scholar]
  2. McGloughlin S, Richards GA, Nor MBM, Prayag S, Baker T, Amin P, , 2017. Sepsis in tropical regions: report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care 46: 115118. [Google Scholar]
  3. Slesak G, Douangdala P, Inthalad S, Silisouk J, Vongsouvath M, Sengduangphachanh A, Moore CE, Mayxay M, Matsuoka H, Newton PN, , 2009. Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann Clin Microbiol Antimicrob 8: 24. [Google Scholar]
  4. Yang CH, Li YH, , 2011. Chromobacterium violaceum infection: a clinical review of an important but neglected infection. J Chin Med Assoc 74: 435441. [Google Scholar]
  5. Macher AM, Casale TB, Fauci AS, , 1982. Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. Ann Intern Med 97: 5155. [Google Scholar]
  6. Madi DR, Vidyalakshmi K, Ramapuram J, Shetty AK, , 2015. Successful treatment of Chromobacterium violaceum sepsis in a south Indian adult. Am J Trop Med Hyg 93: 10661067. [Google Scholar]
  7. Victorica B, Baer H, Ayoub EM, , 1974. Successful treatment of systemic Chromobacterium violaceum infection. JAMA 230: 578580. [Google Scholar]
  8. Censusdata.abs.gov.au, 2018. 2016 Census QuickStats: Cairns. Available at: http://www.censusdata.abs.gov.au/census_services/getproduct/census/2016/quickstat/306?opendocument. Accessed March 7, 2018.
  9. Censusdata.abs.gov.au, 2018. 2016 Census QuickStats: Far North. Available at: http://www.censusdata.abs.gov.au/census_services/getproduct/census/2016/quickstat/31501?opendocument. Accessed March 7, 2018.
  10. Lin Y, Majumdar SS, Hennessy J, Baird RW, , 2016. The spectrum of Chromobacterium violaceum infections from a single geographic location. Am J Trop Med Hyg 94: 710716. [Google Scholar]
  11. Therapeutic Guidelines, 2015. eTG Complete. Melbourne, Australia: Therapeutic Guidelines Limited.
  12. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R, , 2014. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 311: 13081316. [Google Scholar]
  13. Edmiston CE, Garcia R, Barnden M, DeBaun B, Johnson HB, , 2018. Rapid diagnostics for bloodstream infections: a primer for infection preventionists. Am J Infect Control, doi: 10.1016/j.ajic.2018.02.022. [Google Scholar]
  14. Rhodes A, 2017. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43: 304377. [Google Scholar]
  15. Dellinger RP, 2004. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858873. [Google Scholar]
  16. Miki T, , 2014. Virulence determinant of Chromobacterium violaceum. Nihon Saikingaku Zasshi 69: 577588. [Google Scholar]
  17. Miller DP, Blevins WT, Steele DB, Stowers MD, , 1988. A comparative study of virulent and avirulent strains of Chromobacterium violaceum. Can J Microbiol 34: 249255. [Google Scholar]
  18. Pant ND, Acharya SP, Bhandari R, Yadav UN, Saru DB, Sharma M, , 2017. Bacteremia and urinary tract infection caused by Chromobacterium violaceum: case reports from a Tertiary Care Hospital in Kathmandu, Nepal. Case Rep Med 2017: 7929671. [Google Scholar]
  19. Hagiya H, Murase T, Suzuki M, Shibayama K, Kokumai Y, Watanabe N, Maki M, Otsuka F, , 2014. Chromobacterium violaceum nosocomial pneumonia in two Japanese patients at an intensive care unit. J Infect Chemother 20: 139142. [Google Scholar]
  20. Swain B, Otta S, Sahu KK, Panda K, Rout S, , 2014. Urinary tract infection by Chromobacterium violaceum. J Clin Diagn Res 8: Dd01Dd02. [Google Scholar]

Data & Media loading...

  • Received : 12 Apr 2018
  • Accepted : 21 Jun 2018
  • Published online : 13 Aug 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error